Russian strategy in Ukraine under pressure. Longer term impact of military action on economy

Emerging markets will dominate global growth - where 85% of humanity lives. Economy keynote speaker

Trust is the most important thing. Future of logistics and supply chain management - keynote speaker

Future of Sales and Marketing beyond COVID - hybrid event in Vilnius: physical audience of 800 + 300 virtual. Digital marketing, location marketing. How to create MAGIC in new marketing campaigns. Future of Marketing Keynote Speaker

Chances of 2 people in 70 having same birthday? Managing Risk in Banking and Financial Services. Why the greatest risks are combinations of very unlikely events, which happen far more often than you expect. Keynote speaker on risk management

Compliance is Dead. How to build trust. Reputation of banks and financial services. Compliance Risks. Why 100% compliance with regulations, ESG requirements etc is often not enough to prevent reputational damage

Life's too short to do things you don't believe in! Why passionate belief in the true value of what you are selling or doing is the number one key to success. Secret of all leadership and marketing - keynote for 1100 people in Vilnius October 2021

Why you can't innovate on Zoom or Teams meetings - Innovation is almost impossible unless breathing same air, in same room

Why the key to rapid innovation is team diversity - survey global CEOs. Innovation keynote speaker

Future Manufacturing 5.0. Lessons from personal life for all manufacturers. Manufacturing Keynote

Future of Manufacturing: diagnostics; predictive analytics, little data and cybersecurity. Keynote

Manufacturing 5 0: The truth about robots, robotics and automation. Future of Manufacturing Keynote

Celebrex - Arthritis Pain Latest News

Futurist Keynote Speaker: Posts, Slides, Videos - Future Health Care and Pharma Keynote Speaker


New arthritis wonder cure?  Miracle results for rheumatoid arthritis claimed - not for Celebrex but for new treatment which stops the immune system attacking joints.

 

  • Celebrex prevents post-operative pain - 2 Celebrex studies published at American pain Society Meeting.  Health News Daily: 26 October 1999
  • Celebrex may help menstrual pain. Market Letter 25 October 1999
  • 355 million people suffering with arthritis pain could benefit from Celebrex. In US 107,000 people every year land up in hospital because of non-steroidal anti-inflammatory drugs with 16,000 deaths a year.  That's the reason for Celebrex demand because side effects are lower although costs are greater. Business World (Philippines): 25thOctober 1999
  • Sales of Celebrex exceed $1bn - sold by Monsanto. Hottest selling new drug in Pharmaceutical history, even greater than Viagra - or was until Vioxx came along - see below.  Star Ledger New Jersey: 25 October 1999
  • On-line pharmacies selling Viagra, Celebrex, Proscar, Propecia and other prescription only drugs are being sued by the State of Illinois for supplying residents in that State.  More than 300 internet sites offer prescription drugs.  Hundreds of other sites are linked to them.  Indeed this Global Change site has been repeatedly targeted over the last few weeks by on-line pharmacies wanting to sell Viagra or Celebrex... our company policy is to refuse until formal guidelines have been approved by the relevant medical associations for on-line prescribing. Last month, drugstore.com, Merck-Medco Rx Services and PlanetRx.com got a seal of approval from the Boards of Pharmacy association. The web sites targeted by the Viagra / Celebrex and Propecia lawsuits are expresstoday.com, mdhealthline.com, rxclinic.com and maleclinic.com. Fines could be $50,000 per transaction.  Chicago Tribune: 22 October 1999

Vioxx is a competitor for Celebrex.  Vioxx is made by Merck with $208m sales in the first 20 weeks from launch.  More than 2 million scripts in US. Now Vioxx is being introduced in 22 other countries.  Vioxx is being marketed now to US dentists.  Financial Times 22 October 1999


Related news items:
Newer news items:
Older news items:


Thanks for promoting with Facebook LIKE or Tweet. Really interested to read your views. Post below.

Join the Debate! What are your own views?


?

 

Search for your future



Our cookie policy

We use cookies for statistical purposes. To comply with the e-Privacy Directive we need to ask your consent to place these cookies on your computer.

Your use of this site indicates acceptance of these terms. I accept